Literature DB >> 16220676

Evaluation of risk factors for development of catheter-associated jugular thrombophlebitis in horses: 50 cases (1993-1998).

Brett A Dolente1, Jill Beech, Susan Lindborg, Gary Smith.   

Abstract

OBJECTIVE: To evaluate risk factors associated with development of catheter-associated jugular thrombophlebitis in hospitalized horses.
DESIGN: Retrospective case-control study. ANIMALS: 50 horses with thrombophlebitis and 100 control horses. PROCEDURE: Medical records from 1993 through 1998 were searched for horses with thrombophlebitis. Horses that were hospitalized for at least 5 days, had an i.v. catheter placed in a jugular vein (other than for solely anesthetic purposes), and had no evidence of thrombophlebitis during admission or hospitalization were chosen as controls. Signalment, history, clinicopathologic findings, primary illness, and treatment were obtained from the medical records. Data were analyzed by use of logistic regression to perform univariate and multivariate analyses.
RESULTS: For a horse with endotoxemia, the odds of developing thrombophlebitis were 18 times those for a similar horse without endotoxemia. For a horse with salmonellosis, the odds of developing thrombophlebitis were 68 times those for a similar horse without salmonellosis. For a horse with hypoproteinemia, the odds of developing thrombophlebitis were almost 5 times those for a similar horse without hypoproteinemia. For a horse in the medicine section, the odds of developing thrombophlebitis were 16 times those for a similar horse in the surgery section. For a horse with large intestinal dise, the odds of developing thrombophlebitis were 4 times those for a similar horse without large intestinal disease. For a horse receiving antidiarrheal or antiulcerative medications, the odds of developing thrombophlebitis were 31 times those for a similar horse not receiving these medications. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that patient factors, including large intestinal disease, hypoproteinemia, salmonellosis, and endotoxemia, were associated with development of catheter-associated thrombophlebitis in horses.

Entities:  

Mesh:

Year:  2005        PMID: 16220676     DOI: 10.2460/javma.2005.227.1134

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Acute diarrhea in horses: A multicenter Canadian retrospective study (2015 to 2019).

Authors:  Diego E Gomez; Mathilde Leclere; Luis G Arroyo; Lynna Li; Emily John; Tiago Afonso; Flavie Payette; Shannon Darby
Journal:  Can Vet J       Date:  2022-10       Impact factor: 1.075

2.  Thromboelastography in obese horses with insulin dysregulation compared to healthy controls.

Authors:  Amy L Lovett; Lyndi L Gilliam; Benjamin W Sykes; Dianne McFarlane
Journal:  J Vet Intern Med       Date:  2022-04-16       Impact factor: 3.175

Review 3.  Jugular thrombophlebitis in horses: a review of fibrinolysis, thrombus formation, and clinical management.

Authors:  Deborah Penteado Martins Dias; José Corrêa de Lacerda Neto
Journal:  Can Vet J       Date:  2013-01       Impact factor: 1.008

4.  Outcome and complications in horses administered sterile or non-sterile fluids intravenously.

Authors:  Jamie J Kopper; Megan E Bolger; Clark J Kogan; Harold C Schott
Journal:  J Vet Intern Med       Date:  2019-10-14       Impact factor: 3.333

5.  Use of saline contrast ultrasonography in the diagnosis of complete jugular vein occlusion in a horse.

Authors:  Andrea Corda; Nicolò Columbano; Valentina Secchi; Antonio Scanu; Maria Luisa Pinna Parpaglia; Giovanni Mario Careddu; Eraldo Sanna Passino
Journal:  Open Vet J       Date:  2020-09-15

6.  B-mode and color Doppler ultrasonography of normal external jugular vein in donkeys (Equus asinus).

Authors:  Hussein Awad Hussein; Ahmed Ibrahim
Journal:  BMC Vet Res       Date:  2022-09-14       Impact factor: 2.792

7.  Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses.

Authors:  Wolfgang Bäumer; Gudrun M Herrling; Karsten Feige
Journal:  BMC Vet Res       Date:  2013-08-09       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.